Complete withdrawal of immunosuppression in living donor liver transplantation.
Oike
Fumitaka
F
Department of Transplantation and Immunology, Faculty of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507 Japan.
Yokoi
A
A
Nishimura
E
E
Ogura
Y
Y
Fujimoto
Y
Y
Kasahara
M
M
Kaihara
S
S
Kiuchi
T
T
Egawa
H
H
Uemoto
S
S
Tanaka
K
K
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D019520:Living Donors; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D016559:Tacrolimus